Home/Supreme Court/Royce Laboratories, Inc. v. Bristol-Myers Squibb Co.

Royce Laboratories, Inc. v. Bristol-Myers Squibb Co.

516 U.S. 1067, 116 S. Ct. 754, 133 L. Ed. 2d 701, 64 U.S.L.W. 3467, 1996 U.S. LEXIS 378
CourtSupreme Court of the United States
DecidedJanuary 8, 1996
DocketNo. 95-737
StatusPublished

This text of 516 U.S. 1067 (Royce Laboratories, Inc. v. Bristol-Myers Squibb Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Royce Laboratories, Inc. v. Bristol-Myers Squibb Co., 516 U.S. 1067, 116 S. Ct. 754, 133 L. Ed. 2d 701, 64 U.S.L.W. 3467, 1996 U.S. LEXIS 378 (1996).

Opinion

C. A. Fed. Cir. Motion of National Association of Pharmaceutical Manufacturers et al. for leave to file a brief [1068]*1068as amici curiae granted. Certiorari denied.

Justice O’Connor took no part in the consideration or decision of this motion and this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
516 U.S. 1067, 116 S. Ct. 754, 133 L. Ed. 2d 701, 64 U.S.L.W. 3467, 1996 U.S. LEXIS 378, Counsel Stack Legal Research, https://law.counselstack.com/opinion/royce-laboratories-inc-v-bristol-myers-squibb-co-scotus-1996.